STOCK TITAN
  1. Home
  2. Sec-filings
  3. GOSS
  4. [EFFECT] Gossamer Bio, Inc. SEC Filing

[EFFECT] Gossamer Bio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 18, 2026
Accession Number: 0001728117-26-000020
Submission Type: POS AM
CIK: 0001728117
Company Name: Gossamer Bio, Inc.
File Number: 333-293009

Source: View Original Filing on SEC EDGAR

Gossamer Bio

NASDAQ:GOSS

View GOSS Stock Overview →

GOSS Rankings

#5028 Ranked by Market Cap
N/A Ranked by Dividends

GOSS Latest News

Mar 17, 2026
Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Feb 23, 2026
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension
Jan 8, 2026
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Dec 9, 2025
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 24, 2025
Gossamer Bio to Participate in Upcoming Investor Conferences

GOSS Latest SEC Filings

Mar 20, 2026
[Form 4] Gossamer Bio, Inc. Insider Trading Activity
Mar 20, 2026
[Form 4] Gossamer Bio, Inc. Insider Trading Activity
Mar 20, 2026
[Form 4] Gossamer Bio, Inc. Insider Trading Activity
Mar 20, 2026
[Form 4] Gossamer Bio, Inc. Insider Trading Activity
Mar 20, 2026
[Form 4] Gossamer Bio, Inc. Insider Trading Activity

GOSS Stock Data

104.62M
218.57M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO